Role of arginase in asthma: Potential clinical applications

Expert Review of Clinical Pharmacology

Volumn 3, Issue 1, 2010, Pages 17-23

  Munder, Markus ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Airway hyper responsiveness; Arginase; Asthma; Fibrosis; Inflammation; L arginine; Nitric oxide

Indexed keywords

2 AMINO 6 BORONOHEXANOIC ACID; 2 BORONOETHYLCYSTEINE; AMINO ACID TRANSPORTER; ARGINASE; ARGINASE 1; ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CITRULLINE; COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MEPACRINE; N(G) HYDROXYNORARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PIRFENIDONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ALLERGIC ASTHMA; AMINO ACID METABOLISM; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL HYPERPLASIA; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GOBLET CELL; HUMAN; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG FIBROSIS; MEMBRANE TRANSPORT; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; SUPPLEMENTATION;

EID: 77949760895     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/ecp.09.53     Document Type: Review

References (42)

1. Hamid Q, Tulic M. Immunobiology of asthma. Annu. Rev. Physiol. 71, 489-507 (2009).
2. Maarsingh H, Zaagsma J, Meurs H. Arginine homeostasis in allergic asthma. Eur. J. Pharmacol. 585(2-3), 375-384 (2008).
3. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84(3), 731-765 (2004).
4. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 352(21), 2163-2173 (2005).
5. Lara A, Khatri SB, Wang Z et al. Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 178(7), 673-681 (2008).
6. Zimmermann N, King NE, Laporte J et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111(12), 1863-1874 (2003).
7. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 170(2), 148-153 (2004).
8. Li H, Romieu I, Sienra-Monge JJ et al. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J. Allergy Clin. Immunol. 117(1), 119-126 (2006).
9. Litonjua AA, Lasky-Su J, Schneiter K et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am. J. Respir. Crit. Care Med. 178(7), 688-694 (2008).
10. Salam MT, Islam T, Gauderman WJ, Gilliland FD. Roles of arginase variants, atopy, and ozone in childhood asthma. J. Allergy Clin. Immunol. 123(3), 596-602 E591-E598 (2009
11. Bronte V, Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat. Rev. Immunol. 5(8), 641-654 (2005).
12. Munder M, Mollinedo F, Calafat J et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105(6), 2549-2556 (2005).
13. Zimmermann N, Rothenberg ME. The arginine-arginase balance in asthma and lung inflammation. Eur. J. Pharmacol. 533(1-3), 253-262 (2006).
14. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch. Pharmacol. 378(2), 171-184 (2008).
15. Meurs H, McKay S, Maarsingh H et al. Increased arginase activity underlies allergen-induced deficiency of cNOSderived nitric oxide and airway hyperresponsiveness. Br. J. Pharmacol. 136(3), 391-398 (2002).
16. Yang M, Rangasamy D, Matthaei KI et al. Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J. Immunol. 177(8), 5595-5603 (2006).
17. Maarsingh H, Tio MA, Zaagsma J, Meurs H. Arginase attenuates inhibitory nonadrenergic noncholinergic nerveinduced nitric oxide generation and airway smooth muscle relaxation. Respir. Res. 6, 23 (2005).
18. Maarsingh H, Leusink J, Bos IS, Zaagsma J, Meurs H. Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir. Res. 7, 6 (2006).
19. Zhao A, Urban JF Jr, Anthony RM et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135(1), 217-225 e1 (2008).
20. Kitowska K, Zakrzewicz D, Konigshoff M et al. Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294(1), L34-L45 (2008).
21. Takemoto K, Ogino K, Shibamori M et al. Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(6), L1419-L1426 (2007).
22. Liu H, Drew P, Gaugler AC, Cheng Y, Visner GA. Pirfenidone inhibits lung allograft fibrosis through l-argininearginase pathway. Am. J. Transplant. 5(6), 1256-1263 (2005).
23. Mabalirajan U, Aich J, Agrawal A, Ghosh B. Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-b1 in an extended subacute mouse model of allergic asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(3), L411-L419 (2009).
24. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am. J. Respir. Crit. Care Med. 172(12), 1523-1528 (2005).
25. Lindemann D, Racke K. Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced upregulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch. Pharmacol. 368(6), 546-550 (2003).
26. Lee C, Kolesnik TB, Caminschi I et al. Suppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma response. Clin. Exp. Allergy 39(6), 897-907 (2009).
27. Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur. J. Immunol. 38(6), 1689-1699 (2008).
28. Sharkhuu T, Matthaei KI, Forbes E et al. Mechanism of interleukin-25 (IL-17E)- induced pulmonary inflammation and airways hyper-reactivity. Clin. Exp. Allergy 36(12), 1575-1583 (2006).
29. Holgate ST. Pathogenesis of asthma. Clin. Exp. Allergy 38(6), 872-897 (2008).
30. Maarsingh H, Zuidhof AB, Bos IS et al. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am. J. Respir. Crit. Care Med. 178(6), 565-573 (2008).
31. Ckless K, Lampert A, Reiss J et al. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J. Immunol. 181(6), 4255-4264 (2008).
32. Munder M, Schneider H, Luckner C et al. Suppression of T-cell functions by human granulocyte arginase. Blood 108(5), 1627-1634 (2006).
33. Oberlies J, Watzl C, Giese T et al. Regulation of NK cell function by human granulocyte arginase. J. Immunol. 182(9), 5259-5267 (2009).
34. Choi BS, Martinez-Falero IC, Corset C et al. Differential impact of l-arginine deprivation on the activation and effector functions of T cells and macrophages. J. Leukoc. Biol. 85(2), 268-277 (2009).
35. Niese KA, Collier AR, Hajek AR et al. Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol. 10, 33 (2009).
36. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 296(6), L911-L920 (2009).
37. Kenyon NJ, Bratt JM, Linderholm AL, Last MS, Last JA. Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol. Appl. Pharmacol. 230(3), 269-275 (2008).
38. Chibana K, Trudeau JB, Mustovich AT et al. IL-13 induced increases in nitrite levels are primarily driven by increases in inducible l as compared with effects on arginases in human primary bronchial epithelial cells. Clin. Exp. Allergy 38(6), 936-946 (2008).
39. Maarsingh H, Bossenga BE, Bos IS, Volders HH, Zaagsma J, Meurs H. l-arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur. Respir. J. 34(1), 191-199 (2009).
40. Sapienza MA, Kharitonov SA, Horvath I, Chung KF, Barnes PJ. Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 53(3), 172-175 (1998).
41. De Gouw HW, Verbruggen MB, Twiss IM, Sterk PJ. Effect of oral l-arginine on airway hyperresponsiveness to histamine in asthma. Thorax 54(11), 1033-1035 (1999).
42. Schwedhelm E, Maas R, Freese R et al. Pharmacokinetic and pharmacodynamic properties of oral l-citrulline and l-arginine: impact on nitric oxide metabolism. Br. J. Clin. Pharmacol. 65(1), 51-59 (2008).